Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular degeneration

por Coney, Joseph M., Zubricky, Ryan, Sinha, Samriddhi Buxy, Sonbolian, Nina, Zhou, Lujia, Hull, Thomas P., Lewis, Shawn A., Miller, David G., Novak, Michael A., Pendergast, Scott D., Pham, Hang, Platt, Sean M., Rao, Llewelyn J., Schartman, Jerome P., Singerman, Lawrence J., Donkor, Richard, Fink, Margaret, McCoy, Jasmyne, Karcher, Helene
Publicado 2023